Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital

Pharm World Sci. 2003 Dec;25(6):299-302. doi: 10.1023/b:phar.0000006524.52076.2f.

Abstract

Objectives: To analyse clinical pharmacists interventions in the ICU of the Penang General Hospital (Penang, Malaysia) and to assess the pharmaco-economic impact of these interventions.

Methods: A clinical pharmacist reviewed drug prescriptions during one month. Drug-related problems were documented on a prepared from including a suggestion for a change in prescribing. Such recommendations were submitted to the nursing/medical staff. Acceptance of the recommendation was entirely at the discretion of the medical staff. All recommendations were analysed with respect to potential pharmaco-economic impact: cost savings, cost avoidance or cost addition.

Results: The ICU pharmacist made 57 recommendations, of which the medical staff rejected only 5%. The majority of detected drug-related problems referred to unnecessary drug therapy (37%). Recommendations resulted in net cost savings of RM 15,227 (USD 4,007). This corresponded with RM 634 per patient intervened by the pharmacist.

Conclusion: Pharmacists interventions in the ICU of a Malaysian hospital resulted in significant cost savings in terms of drug expenses and can therefore be suggested as a routine practice in our hospital.

MeSH terms

  • Cost Savings / economics
  • Drug Utilization Review / economics*
  • Humans
  • Intensive Care Units / economics*
  • Malaysia
  • Pharmacists*
  • Pharmacy Service, Hospital / economics
  • Professional Role*